← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2014Last known activity
Dec 31, 2025
Timeline
2000s
- Jan 1, 2009
Suzhou Zelgen Biopharmaceuticals Co.,Ltd— Founded
Drugs by trial phase (34 distinct, 81 trials)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
- Alopecia
- Alopecia Areata
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Dermatitis
- Dermatitis, Atopic
- Digestive System Neoplasms
- Eczema
- Esophageal Neoplasms
- Fibrosis
- Gastrointestinal Neoplasms
- Idiopathic Pulmonary Fibrosis
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Nasopharyngeal Carcinoma
- Neoplasms
- Primary Myelofibrosis
- Psoriasis
- Pulmonary Fibrosis
- Spondylitis
- Spondylitis, Ankylosing
- Stomach Neoplasms
- Thyroid Diseases
- Thyroid Neoplasms
Recent trials (50)
- NCT07258121Lead sponsorPhase 1/Phase 2Dec 31, 2025
- NCT07231445OfficialPhase 1Dec 23, 2025
- NCT07231445Lead sponsorPhase 1Dec 23, 2025
- NCT07189455OfficialPhase 3Nov 30, 2025
- NCT07189455Lead sponsorPhase 3Nov 30, 2025
- NCT07142837Lead sponsorPhase 1/Phase 2Sep 30, 2025
- NCT07099547Lead sponsorPhase 2Sep 30, 2025
- NCT07099547OfficialPhase 2Sep 30, 2025
- NCT07142837OfficialPhase 1/Phase 2Sep 30, 2025
- NCT07038096Lead sponsorPhase 1/Phase 2Aug 31, 2025
- NCT07080216Lead sponsorPhase 1/Phase 2Aug 31, 2025
- NCT07024277Lead sponsorPhase 2Aug 31, 2025
- NCT07024277OfficialPhase 2Aug 31, 2025
- NCT07038096OfficialPhase 1/Phase 2Aug 31, 2025
- NCT07080216OfficialPhase 1/Phase 2Aug 31, 2025
Details
- Founded
- Suzhou, CN Jan 1, 2009
- Last known activity
- Dec 31, 2025